Comparable stake leader
VANGUARD CAPITAL MANAGEMENT LLC
SEC ownership of Medtronic plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001613103.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- MDT on NYSE
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001613103
- Issuer location
- Galway
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Medtronic plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.5%
13D/G row: VANGUARD CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.5%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD CAPITAL MANAGEMENT LLC
7.5%
BlackRock, Inc.
6.9%
Kendall J. Powell
0%
Randall J. Hogan
0%
Craig Arnold
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.5%
|
$8,355,143,413
96,424,044 shares
|
$0 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.9%
from 13D/G
|
$8,919,846,142
114,020,787 shares
|
— | 30 Jun 2026 |
| Kendall J. Powell |
3/4/5
Director
|
0%
|
$4,452,077
51,380 shares
|
— | 27 Apr 2026 |
| Randall J. Hogan |
3/4/5
Director
|
0%
|
$4,245,676
48,998 shares
|
— | 27 Apr 2026 |
| Craig Arnold |
3/4/5
Director
|
0%
|
$3,655,330
42,185 shares
|
— | 27 Apr 2026 |
| Scott C. Donnelly |
3/4/5
Director
|
0%
|
$2,051,785
23,679 shares
|
— | 27 Apr 2026 |
| Elizabeth G. Nabel |
3/4/5
Director
|
0%
|
$1,696,953
19,584 shares
|
— | 27 Apr 2026 |
| Andrea Jo Goldsmith |
3/4/5
Director
|
0%
|
$866,896
10,247 shares
|
— | 28 Apr 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$9,110,863.
Buys
$462,750
Insiders: 1
Sells
$9,573,613
Insiders: 3
Net
-$9,110,863
Shares: -93,420
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 5,000
Shares: 98,420
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 7,291 | $0 | $594,897 | -$594,897 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 52,524 | $0 | $5,132,217 | -$5,132,217 |
| 9-12 | 5,000 | 38,605 | $462,750 | $3,846,499 | -$3,383,749 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 35 reporting-owner rows connected to Medtronic plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
35
Largest Forms 3/4/5 holder
Geoffrey Martha
Net 12M change
-$9,342,688
Latest report
03 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Geoffrey Martha | Chairman and CEO, Director | $25,648,957 | Median | 31 Jul 2026 | ||
| Richard H. Anderson | Director | $9,885,298 | Mixed | 01 May 2023 | ||
| Michael Marinaro | EVP, Pres MedSurg and Americas | $9,185,766 | Median | 31 Jul 2026 | ||
| Karen L. Parkhill | EVP & Chief Financial Officer | $8,079,108 | Mixed | 02 Aug 2024 | ||
| Brett A. Wall | EVP & Pres Neuroscience | $7,121,156 | Mixed | 26 May 2026 | ||
| Denise M. Oleary | Director | $6,233,141 | Mixed | 01 May 2024 | ||
| Richard Kuntz | SVP & Chief Medical & Science | $6,158,231 | Mixed | 05 Nov 2021 | ||
| Sean Salmon | EVP & President Cardiovascular | $5,338,271 | Mixed | 16 Dec 2024 | ||
| Gregory L. Smith | EVP Global Ops & Supply Chain | $4,697,313 | -$3,058,451 | -39% | Filing P/S | 19 Nov 2025 |
| Ivan K. Fong | Evp General Counsel & Secr | $4,510,996 | Mixed | 16 Dec 2024 | ||
| Kendall J. Powell | Director | $4,452,077 | Mixed | 27 Apr 2026 | ||
| Hoedt Rob Ten | EVP and Pres. Global Regions | $4,334,303 | Mixed | 03 Aug 2023 | ||
| Randall J. Hogan | Director | $4,245,676 | Mixed | 27 Apr 2026 | ||
| Robert John White | EVP & Pres. Medical Surgical | $4,101,105 | Mixed | 08 Dec 2023 | ||
| Bradley E. Lerman | SVP General Counsel & Corp Sec | $3,996,338 | Mixed | 05 Nov 2021 | ||
| Thierry Pieton | EVP & Chief Financial Officer | $3,883,728 | Median | 03 Aug 2026 | ||
| Craig Arnold | Director | $3,655,330 | Mixed | 27 Apr 2026 | ||
| Gary Louis Corona | Interim CFO | $3,558,545 | Mixed | 21 Jan 2025 | ||
| Harry Skip Kiil | EVP & President Cardiovascular | $3,416,225 | -$6,257,231 | -65% | Median | 31 Jul 2026 |
| Matthew R. Walter | SVP, Chief HR Officer | $3,123,567 | -$257,931 | -7.6% | Median | 31 Jul 2026 |
Recent insider transactions for Medtronic plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Denise L. Blomquist | MDT | Ordinary Shares | Award | 15.9% | 2,337 | 16,998 | 03 Aug 2026 | Direct | ||
| Denise L. Blomquist | MDT | Stock Option (Right to Buy) | Award | 1,366 | 1,366 | 03 Aug 2026 | Direct | |||
| Denise L. Blomquist | MDT | Performance Share Units | Award | 2,337 | 2,337 | 03 Aug 2026 | Direct | |||
| Matthew R. Walter | MDT | Ordinary Shares | Award | 16.9% | 5,769 | 39,928 | 03 Aug 2026 | Direct | ||
| Matthew R. Walter | MDT | Stock Option (Right to Buy) | Award | 40,973 | 40,973 | 03 Aug 2026 | Direct | |||
| Matthew R. Walter | MDT | Performance Share Units | Award | 14,421 | 14,421 | 03 Aug 2026 | Direct | |||
| Kweli Thompson | MDT | Ordinary Shares | Award | 24.3% | 6,923 | 35,390 | 03 Aug 2026 | Direct | ||
| Kweli Thompson | MDT | Stock Option (Right to Buy) | Award | 49,167 | 49,167 | 03 Aug 2026 | Direct | |||
| Kweli Thompson | MDT | Performance Share Units | Award | 17,306 | 17,306 | 03 Aug 2026 | Direct | |||
| Michelle Quinn | MDT | Ordinary Shares | Award | 31.2% | 6,346 | 26,721 | 03 Aug 2026 | Direct | ||
| Michelle Quinn | MDT | Stock Option (Right to Buy) | Award | 45,070 | 45,070 | 03 Aug 2026 | Direct | |||
| Michelle Quinn | MDT | Performance Share Units | Award | 15,863 | 15,863 | 03 Aug 2026 | Direct | |||
| Thierry Pieton | MDT | Ordinary Shares | Award | 30.3% | 11,537 | 49,645 | 03 Aug 2026 | Direct | ||
| Thierry Pieton | MDT | Stock Option (Right to Buy) | Award | 81,945 | 81,945 | 03 Aug 2026 | Direct | |||
| Thierry Pieton | MDT | Performance Share Units | Award | 28,842 | 28,842 | 03 Aug 2026 | Direct | |||
| Michael Marinaro | MDT | Ordinary Shares | Award | 94.7% | 57,107 | 117,420 | 03 Aug 2026 | Direct | ||
| Michael Marinaro | MDT | Stock Option (Right to Buy) | Award | 77,848 | 77,848 | 03 Aug 2026 | Direct | |||
| Michael Marinaro | MDT | Performance Share Units | Award | 27,400 | 27,400 | 03 Aug 2026 | Direct | |||
| Harry Skip Kiil | MDT | Ordinary Shares | Award | 26.8% | 9,230 | 43,669 | 03 Aug 2026 | Direct | ||
| Harry Skip Kiil | MDT | Stock Option (Right to Buy) | Award | 65,556 | 65,556 | 03 Aug 2026 | Direct | |||
| Harry Skip Kiil | MDT | Performance Share Units | Award | 23,074 | 23,074 | 03 Aug 2026 | Direct | |||
| Geoffrey Martha | MDT | Ordinary Shares | Award | 14.5% | 41,533 | 327,866 | 03 Aug 2026 | Direct | ||
| Geoffrey Martha | MDT | Stock Option (Right to Buy) | Award | 568,152 | 295,002 | 03 Aug 2026 | Direct | |||
| Geoffrey Martha | MDT | Performance Share Units | Award | 103,831 | 103,831 | 03 Aug 2026 | Direct | |||
| Denise L. Blomquist | MDT | Ordinary Shares | Tax liability | -1.43% | -212 | 14,661 | 31 Jul 2026 | Direct | ||
| Matthew R. Walter | MDT | Ordinary Shares | Tax liability | -4.67% | -1,675 | 34,159 | 31 Jul 2026 | Direct | ||
| Kweli Thompson | MDT | Ordinary Shares | Tax liability | -5.76% | -1,739 | 28,467 | 31 Jul 2026 | Direct | ||
| Michael Marinaro | MDT | Ordinary Shares | Tax liability | -5.27% | -3,356 | 60,313 | 31 Jul 2026 | Direct | ||
| Harry Skip Kiil | MDT | Ordinary Shares | Tax liability | -8.19% | -3,074 | 34,439 | 31 Jul 2026 | Direct | ||
| Geoffrey Martha | MDT | Ordinary Shares | Tax liability | -5.23% | -15,810 | 286,333 | 31 Jul 2026 | Direct | ||
| Michelle Quinn | MDT | Ordinary Shares | Tax liability | -9.22% | -2,069 | 20,375 | 28 Jul 2026 | Direct | ||
| Matthew R. Walter | MDT | Ordinary Shares | Sale | -8% | $257,931 | $83.15 | -3,102 | 35,694 | 08 Jul 2026 | Direct |
| Harry Skip Kiil | MDT | Ordinary Shares | Sale | -10.1% | $336,965 | $80.44 | -4,189 | 37,227 | 08 Jun 2026 | Direct |
| Denise L. Blomquist | MDT | Ordinary Shares | Tax liability | -1.58% | -237 | 14,737 | 05 Jun 2026 | Direct | ||
| Harry Skip Kiil | MDT | Ordinary Shares | Tax liability | -14.1% | -6,817 | 41,416 | 04 Jun 2026 | Direct | ||
| Geoffrey Martha | MDT | Ordinary Shares | Tax liability | -12.2% | -41,936 | 301,163 | 04 Jun 2026 | Direct | ||
| Michael Marinaro | MDT | Ordinary Shares | Tax liability | -10.6% | -7,471 | 63,122 | 04 Jun 2026 | Direct | ||
| Matthew R. Walter | MDT | Ordinary Shares | Tax liability | -6.84% | -2,840 | 38,689 | 04 Jun 2026 | Direct | ||
| Matthew R. Walter | MDT | Ordinary Shares | Options Exercise | 28.3% | 9,149 | 41,529 | 26 May 2026 | Direct | ||
| Matthew R. Walter | MDT | Performance Share Unit | Options Exercise | -100% | -8,449 | 0 | 26 May 2026 | Direct | ||
| Brett A. Wall | MDT | Ordinary Shares | Options Exercise | 48.7% | 26,907 | 82,183 | 26 May 2026 | Direct | ||
| Brett A. Wall | MDT | Performance Share Unit | Options Exercise | -100% | -24,214 | 0 | 26 May 2026 | Direct | ||
| Geoffrey Martha | MDT | Ordinary Shares | Options Exercise | 38.3% | 94,963 | 343,099 | 26 May 2026 | Direct | ||
| Geoffrey Martha | MDT | Performance Share Unit | Options Exercise | -100% | -85,461 | 0 | 26 May 2026 | Direct | ||
| Michael Marinaro | MDT | Ordinary Shares | Options Exercise | 36.8% | 18,994 | 70,593 | 26 May 2026 | Direct | ||
| Michael Marinaro | MDT | Performance Share Unit | Options Exercise | -100% | -17,093 | 0 | 26 May 2026 | Direct | ||
| Harry Skip Kiil | MDT | Ordinary Shares | Options Exercise | 46% | 15,195 | 48,233 | 26 May 2026 | Direct | ||
| Harry Skip Kiil | MDT | Performance Share Unit | Options Exercise | -100% | -14,517 | 0 | 26 May 2026 | Direct | ||
| Denise L. Blomquist | MDT | Ordinary Shares | Options Exercise | 12.9% | 1,712 | 14,974 | 26 May 2026 | Direct | ||
| Denise L. Blomquist | MDT | Performance Share Unit | Options Exercise | -100% | -1,621 | 0 | 26 May 2026 | Direct |
* marks a reported price that did not pass the local price check.